H2S supplementation: A novel method for successful organ preservation at subnormothermic temperatures

Publication date: Available online 25 October 2018Source: Nitric OxideAuthor(s): Smriti Juriasingani, Masoud Akbari, Justin YH. Chan, Matthew Whiteman, Alp SenerAbstractRenal transplantation is the preferred treatment for end-stage renal disease. Currently, there is a large gap between the supply and demand for transplantable kidneys. The use of sub-optimal grafts obtained via donation after cardiac death (DCD) is on the rise. While static cold storage (SCS) in University of Wisconsin (UW) solution on ice (4 °C) is the clinical standard of care for renal graft preservation, cold storage has been associated with negative graft outcomes. The alternative, normothermic machine perfusion, involves mechanical perfusion of the organ at physiological or normothermic temperature (37 °C) and this technique is expensive, complicated and globally inaccessible. As such, simpler alternatives are of interest. Preliminary results revealed that UW solution is more protective at 21 °C than 37 °C and subnormothermic preservation is of interest because it may facilitate the use of existing solutions while preventing cold injury. We have previously shown that SCS in UW solution supplemented with mitochondria-targeted H2S donor AP39 improves renal graft outcomes. As such, it was hypothesized subnormothermic preservation at 21 °C with AP39 will also improve renal outcomes. Using an in vitro model of hypoxia and reoxygenation, we found that treating porcine tubular epithelial cells wi...
Source: Nitric Oxide - Category: Chemistry Source Type: research